PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $290,000 | -71.3% | 89,269 | -80.9% | 0.00% | -50.0% |
| Q3 2019 | $1,012,000 | -47.1% | 468,490 | -23.1% | 0.00% | -60.0% |
| Q2 2019 | $1,912,000 | -17.1% | 608,890 | -1.8% | 0.01% | -16.7% |
| Q1 2019 | $2,307,000 | +24.0% | 620,290 | -3.3% | 0.01% | +20.0% |
| Q4 2018 | $1,860,000 | +3.3% | 641,390 | -6.3% | 0.01% | +25.0% |
| Q3 2018 | $1,801,000 | +14.0% | 684,693 | +1.4% | 0.00% | 0.0% |
| Q2 2018 | $1,580,000 | -27.9% | 675,093 | -9.5% | 0.00% | -33.3% |
| Q1 2018 | $2,192,000 | -10.0% | 745,593 | -16.1% | 0.01% | -14.3% |
| Q4 2017 | $2,435,000 | -23.6% | 888,693 | -5.5% | 0.01% | -22.2% |
| Q3 2017 | $3,189,000 | +51.5% | 940,593 | +10.4% | 0.01% | +28.6% |
| Q2 2017 | $2,105,000 | -3.2% | 852,055 | -11.1% | 0.01% | 0.0% |
| Q1 2017 | $2,175,000 | +0.4% | 958,293 | -6.2% | 0.01% | -12.5% |
| Q4 2016 | $2,166,000 | -32.9% | 1,021,674 | +6.1% | 0.01% | -42.9% |
| Q3 2016 | $3,227,000 | -2.6% | 963,312 | -8.7% | 0.01% | -17.6% |
| Q2 2016 | $3,313,000 | -30.3% | 1,055,112 | -26.1% | 0.02% | -37.0% |
| Q1 2016 | $4,755,000 | -9.6% | 1,427,812 | -3.9% | 0.03% | -12.9% |
| Q4 2015 | $5,261,000 | -24.8% | 1,486,232 | +7.6% | 0.03% | -29.5% |
| Q3 2015 | $6,993,000 | -26.0% | 1,381,290 | -6.0% | 0.04% | -39.7% |
| Q2 2015 | $9,449,000 | -10.5% | 1,469,497 | -2.1% | 0.07% | -9.9% |
| Q1 2015 | $10,556,000 | +164.6% | 1,500,509 | +189.9% | 0.08% | +153.1% |
| Q4 2014 | $3,990,000 | -37.3% | 517,509 | -39.2% | 0.03% | -36.0% |
| Q3 2014 | $6,360,000 | -28.5% | 851,409 | -7.4% | 0.05% | -28.6% |
| Q2 2014 | $8,901,000 | -22.6% | 919,509 | -33.5% | 0.07% | -33.3% |
| Q1 2014 | $11,498,000 | +20.1% | 1,383,609 | +22.0% | 0.10% | +14.1% |
| Q4 2013 | $9,573,000 | -32.3% | 1,134,109 | -36.1% | 0.09% | -45.6% |
| Q3 2013 | $14,146,000 | +30.6% | 1,774,909 | +26.5% | 0.17% | +9.0% |
| Q2 2013 | $10,832,000 | – | 1,403,055 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |